US Stock MarketDetailed Quotes

CYCN Cyclerion Therapeutics

Watchlist
  • 2.8200
  • -0.2200-7.24%
Close May 2 16:00 ET
7.64MMarket Cap-1253P/E (TTM)

Cyclerion Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
86.47%-5.49M
301.77%14.21M
30.06%-6.94M
39.41%-6.56M
51.59%-6.21M
-11.21%-40.61M
18.39%-7.04M
-25.14%-9.92M
-96.37%-10.82M
11.21%-12.84M
Net income from continuing operations
88.06%-5.26M
76.52%-1.69M
172.08%7.57M
68.77%-4.18M
46.42%-6.95M
14.66%-44.08M
33.03%-7.22M
7.04%-10.5M
17.27%-13.39M
3.14%-12.98M
Depreciation and amortization
--0
--0
--0
--0
--0
-86.23%65K
--0
--0
-85.59%17K
-81.40%48K
Change In working capital
-61.44%-4.6M
105.26%50K
-104.63%-2.21M
-422.37%-2.75M
118.78%314K
-302.41%-2.85M
-130.54%-951K
-219.05%-1.08M
-14.60%854K
53.74%-1.67M
-Change in receivables
2,300.00%96K
--0
--0
--96K
--0
-85.19%4K
125.86%131K
--0
--0
-200.00%-127K
-Change in prepaid assets
195.12%363K
205.58%284K
186.49%318K
-232.50%-477K
401.27%238K
209.82%123K
26.50%-269K
-45.59%111K
-19.28%360K
80.05%-79K
-Change in payables and accrued expense
-60.24%-5.54M
71.73%-255K
-96.98%-2.61M
-815.79%-2.58M
93.98%-96K
-449.29%-3.46M
-127.38%-902K
-256.57%-1.32M
-15.46%361K
55.43%-1.59M
-Change in other current assets
0.00%481K
-76.40%21K
-41.98%76K
59.40%212K
34.38%172K
-68.99%481K
-30.47%89K
670.59%131K
-66.83%133K
-87.26%128K
Cash from discontinued investing activities
-15.75M
0
Operating cash flow
47.69%-21.25M
78.12%-1.54M
30.06%-6.94M
39.41%-6.56M
51.59%-6.21M
-11.21%-40.61M
18.39%-7.04M
-25.14%-9.92M
-96.37%-10.82M
11.21%-12.84M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow
--10.4M
--0
----
----
----
--0
--0
----
----
----
Financing cash flow
Cash flow from continuing financing activities
17,224.14%5.02M
0
0
-99.91%29K
-85.88%12K
0
Net common stock issuance
----
----
--0
----
----
----
----
--0
----
----
Proceeds from stock option exercised by employees
17,224.14%5.02M
41,566.67%5M
--0
----
----
-89.72%29K
-85.88%12K
--0
----
----
Cash from discontinued financing activities
Financing cash flow
17,224.14%5.02M
--0
--0
----
----
-99.91%29K
-85.88%12K
--0
----
----
Net cash flow
Beginning cash position
-75.20%13.38M
-55.36%9.11M
-81.40%5.64M
-82.57%7.17M
-75.20%13.38M
-7.33%53.96M
-67.35%20.41M
-56.92%30.32M
-9.15%41.13M
-7.33%53.96M
Current changes in cash
85.66%-5.82M
78.08%-1.54M
134.97%3.47M
85.83%-1.53M
51.59%-6.21M
-849.29%-40.58M
17.72%-7.03M
-25.71%-9.92M
-142.99%-10.8M
1.01%-12.84M
Effect of exchange rate changes
166.67%8K
-50.00%4K
--0
400.00%3K
200.00%1K
-25.00%3K
166.67%8K
---3K
-200.00%-1K
---1K
End cash Position
-43.42%7.57M
-43.42%7.57M
-55.36%9.11M
-81.40%5.64M
-82.57%7.17M
-75.20%13.38M
-75.20%13.38M
-67.35%20.41M
-56.92%30.32M
-9.15%41.13M
Free cash flow
47.69%-21.25M
78.12%-1.54M
30.06%-6.94M
39.41%-6.56M
51.59%-6.21M
-11.19%-40.61M
18.39%-7.04M
-25.03%-9.92M
-96.37%-10.82M
11.21%-12.84M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 86.47%-5.49M301.77%14.21M30.06%-6.94M39.41%-6.56M51.59%-6.21M-11.21%-40.61M18.39%-7.04M-25.14%-9.92M-96.37%-10.82M11.21%-12.84M
Net income from continuing operations 88.06%-5.26M76.52%-1.69M172.08%7.57M68.77%-4.18M46.42%-6.95M14.66%-44.08M33.03%-7.22M7.04%-10.5M17.27%-13.39M3.14%-12.98M
Depreciation and amortization --0--0--0--0--0-86.23%65K--0--0-85.59%17K-81.40%48K
Change In working capital -61.44%-4.6M105.26%50K-104.63%-2.21M-422.37%-2.75M118.78%314K-302.41%-2.85M-130.54%-951K-219.05%-1.08M-14.60%854K53.74%-1.67M
-Change in receivables 2,300.00%96K--0--0--96K--0-85.19%4K125.86%131K--0--0-200.00%-127K
-Change in prepaid assets 195.12%363K205.58%284K186.49%318K-232.50%-477K401.27%238K209.82%123K26.50%-269K-45.59%111K-19.28%360K80.05%-79K
-Change in payables and accrued expense -60.24%-5.54M71.73%-255K-96.98%-2.61M-815.79%-2.58M93.98%-96K-449.29%-3.46M-127.38%-902K-256.57%-1.32M-15.46%361K55.43%-1.59M
-Change in other current assets 0.00%481K-76.40%21K-41.98%76K59.40%212K34.38%172K-68.99%481K-30.47%89K670.59%131K-66.83%133K-87.26%128K
Cash from discontinued investing activities -15.75M0
Operating cash flow 47.69%-21.25M78.12%-1.54M30.06%-6.94M39.41%-6.56M51.59%-6.21M-11.21%-40.61M18.39%-7.04M-25.14%-9.92M-96.37%-10.82M11.21%-12.84M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow --10.4M--0--------------0--0------------
Financing cash flow
Cash flow from continuing financing activities 17,224.14%5.02M00-99.91%29K-85.88%12K0
Net common stock issuance ----------0------------------0--------
Proceeds from stock option exercised by employees 17,224.14%5.02M41,566.67%5M--0---------89.72%29K-85.88%12K--0--------
Cash from discontinued financing activities
Financing cash flow 17,224.14%5.02M--0--0---------99.91%29K-85.88%12K--0--------
Net cash flow
Beginning cash position -75.20%13.38M-55.36%9.11M-81.40%5.64M-82.57%7.17M-75.20%13.38M-7.33%53.96M-67.35%20.41M-56.92%30.32M-9.15%41.13M-7.33%53.96M
Current changes in cash 85.66%-5.82M78.08%-1.54M134.97%3.47M85.83%-1.53M51.59%-6.21M-849.29%-40.58M17.72%-7.03M-25.71%-9.92M-142.99%-10.8M1.01%-12.84M
Effect of exchange rate changes 166.67%8K-50.00%4K--0400.00%3K200.00%1K-25.00%3K166.67%8K---3K-200.00%-1K---1K
End cash Position -43.42%7.57M-43.42%7.57M-55.36%9.11M-81.40%5.64M-82.57%7.17M-75.20%13.38M-75.20%13.38M-67.35%20.41M-56.92%30.32M-9.15%41.13M
Free cash flow 47.69%-21.25M78.12%-1.54M30.06%-6.94M39.41%-6.56M51.59%-6.21M-11.19%-40.61M18.39%-7.04M-25.03%-9.92M-96.37%-10.82M11.21%-12.84M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg